Motaz Al Yafi

Motaz Al Yafi

Auto-generated profile, based on publicly available information

Motaz Al Yafi

Division of Cardiothoracic Surgery, Department of Surgery, Pauley Heart Center (Y.I.C.K., D.T.Z., A.M.-G.P., M.K., M.A., J.P., M.A.-Y., P.N., V.K., Z.A.H.), Virginia Commonwealth University School of Medicine, Richmond

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 July 2022 in Surgery
Verified
Journal Article
Closed access
AHAustin C. Hammaker
Austin C. Hammaker
SDShah-Jahan M. Dodwad
Shah-Jahan M. Dodwad
CSChristen E. Salyer
Christen E. Salyer
SASasha D. Adams
Sasha D. Adams
DFDarci C. Foote
Darci C. Foote
ACAlexander R. Cortez
Alexander R. Cortez

22 April 2022 in Vascular
Verified
Journal Article
Closed access
MYMotaz Al Yafi
Motaz Al Yafi
ANAbdullah Nasif
Abdullah Nasif
LGLogan Donald Glosser
Logan Donald Glosser
GRGang Ren
Gang Ren
AAAyman Ahemd
Ayman Ahemd
MOMohamed Osman
Mohamed Osman
Objectives: Non-traumatic lower extremity amputation (LEA) is associated with significant morbidity and mortality. Diabetes mellitus (DM) and peripheral vascular disease (PVD) are associated with increased risk for LEA. As such, DM and PVD account for 54% of all LEA’s, performed in the United States annually. As obesity is highly associated with both DM and PVD, our study sought to explore the relationship between LEA and obesity defined by BMI. Methods: Using the National Inpatient Sample (NIS) database, a retrospective review of patients who underwent non-traumatic LEA (LEA) between 2008 and 2014 was performed. The International Classification of Diseases 9th edition (ICD-9) codes were utilized to determine the diagnoses, comorbidities, and procedures. Patient BMIs were classified as follows: Non-obese [BMI <30], Obesity class I [BMI 30–34.9], Obesity class II [BMI 35–39.9], and Obesity class III [BMI ≥40]. Predictors for LEA were compared between groups using chi-square test and binary logistic regression to identify possible underlying factors associated with LEA. We also conducted a multivariate analysis to measure the effect of multiple variables on LEA. Results: We identified 16,259 patients with non-traumatic LEA and a mean age of 59.9 years. Rate of amputation in females was lower than males at 0.35% vs 0.87% respectively ( p < 0.001). Of patients that underwent amputation there was a V-shape trend based on BMI, with 30.4% in non-obese patients, 18.2% in obesity class I, 17.3% in obesity class II, and 34.1% in obesity class III. The incidence of diabetes increased with obesity class, while the incidence of PVD decreased. Interestingly, of those with DM there was an inverse relationship between amputation rate and BMI class, with LEA rates in non-obese versus obesity class III patients were 1.63% vs 0.98% respectively ( p < 0.001). Similarly, patients who had both diabetes and PVD showed a downward trend in LEA rate as obesity class increased; non-obese patients had a LEA rate of 8.01%, while obesity class III had 4.65% ( p < 0.001). Patients in higher income bracket have lower odds of LEA (OR 0.77, p < 0.001) compared to the lowest income patients. Also, patients with comorbidities such as PVD (OR 10.78), diabetes (OR 5.02), renal failure (OR 1.41), and hypertension (OR 1.36) had higher odds to get an LEA ( p < 0.001). Individuals with obesity class III are almost at half the odds (OR 0.52) to get an LEA compared to non-obese ( p < 0.001). Conclusions: Higher BMI and female gender are protective factors against lower extremity amputation. Factors that predisposing to LEA include lower household income and certain comorbidities such as PVD, diabetes, renal failure, and hypertension. These findings warrant further research to identify patients at high risk for LEA and help develop management guidelines for targeted populations.

1 June 2026 in Circulation: Population Health and Outcomes
Verified
Journal Article
Closed access
YKYe In Christopher Kwon
Ye In Christopher Kwon
DZDavid T. Zhu
David T. Zhu
APAndrew Min-Gi Park
Andrew Min-Gi Park
MKMichael Keller
Michael Keller
MAMatthew Ambrosio
Matthew Ambrosio
ZHZubair A. Hashmi
Zubair A. Hashmi
BACKGROUND: Heart transplantation in the United States is increasingly performed amid expanding Medicare and Medicaid coverage. We analyzed the impact of recipient insurance trajectories on long-term graft and recipient survival following the 2018 United Network for Organ Sharing heart allocation change. METHODS: Adults aged 18 to 64 years undergoing first-time heart transplantation between October 2018 and March 2024 were identified from the national United Network for Organ Sharing solid-organ transplant registry. Recipients surviving ≥1 year were stratified by insurance trajectory across waitlisting, transplantation, and 1-year follow-up into 5 groups: continuous private, continuous public (Medicaid, Medicare, or Veterans Affairs), private-to-public transition, public-to-private transition, and multiple transitions. All-cause mortality and graft failure through 5 years posttransplant were assessed using Kaplan-Meier and multivariable Cox proportional hazards models with continuous private insurance as the referent. RESULTS: Among 15 864 recipients (mean age, 50.9±11.4 years; 31% female), 42.5% had continuous private insurance, 33.9% continuous public, 12.6% private-to-public, 4.8% public-to-private, and 6.3% multiple transitions. Five-year mortality was higher with continuous public insurance (15.1%) and multiple transitions (14.6%) than with continuous private (11.9%), and 5-year graft failure followed the same pattern (4.3% and 3.6% versus 3.2%). Continuous public insurance (hazard ratio [HR], 1.27 [95% CI, 1.15–1.40]) and multiple transitions (HR, 1.19 [95% CI, 1.12–1.43]) were independently associated with increased mortality. Continuous public insurance (HR, 1.29 [95% CI, 1.06–1.56]), private-to-public transition (HR, 1.32 [95% CI, 1.03–1.71]), and multiple transitions (HR, 1.09 [95% CI, 1.07–1.55]) elevated graft failure risk; public-to-private transition was associated with lowered risk (HR, 0.73 [95% CI, 0.45–0.92]). Residence in distressed communities was independently associated with increased mortality (HR, 1.21 [95% CI, 1.12–1.57]) and graft failure (HR, 1.31 [95% CI, 1.20–1.41]). CONCLUSIONS: Public insurance and insurance instability are associated with worse heart transplantation outcomes, while gaining private insurance was associated with improved outcomes, highlighting disparities in posttransplant care.

26 March 2026 in JACC: Case Reports
Verified
Journal Article
Open access
MYMotaz Al Yafi
Motaz Al Yafi
SPSwetha Pasala
Swetha Pasala
VRValentina Robila
Valentina Robila
CTCory Trankle
Cory Trankle
BKBharadhwaj Kolipakkam
Bharadhwaj Kolipakkam
PNPatricia Nicolato
Patricia Nicolato
Rosai-Dorfman disease (RDD) is a rare, benign histiocytic disorder that most often presents with nodal involvement. Cardiac involvement is exceedingly uncommon and poses significant diagnostic and therapeutic challenges. A 51-year-old woman presented with shortness of breath and palpitations and was found to have monomorphic ventricular tachycardia. Imaging revealed a left ventricular mass, and biopsy confirmed RDD. The lesion was surgically excised with cryoablation and CorMatrix reinforcement. The patient recovered uneventfully and remains disease free 25 months postoperatively. RDD with cardiac involvement has been reported in only approximately 25 cases, with very few affecting the left ventricle. This case demonstrates how comprehensive imaging and deep myocardial biopsy are essential for accurate diagnosis. Surgical resection remains the treatment of choice for localized disease. Cardiac RDD, though rare, should be included in the differential diagnosis of infiltrative cardiac masses. Complete excision offers curative potential.